JP2008501649A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008501649A5 JP2008501649A5 JP2007513783A JP2007513783A JP2008501649A5 JP 2008501649 A5 JP2008501649 A5 JP 2008501649A5 JP 2007513783 A JP2007513783 A JP 2007513783A JP 2007513783 A JP2007513783 A JP 2007513783A JP 2008501649 A5 JP2008501649 A5 JP 2008501649A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- formula
- lower alkyl
- alkyl group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003884 phenylalkyl group Chemical group 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04102460 | 2004-06-02 | ||
| PCT/EP2005/005594 WO2005117865A1 (en) | 2004-06-02 | 2005-05-24 | Naphthaline derivatives useful as histamine-3-receptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008501649A JP2008501649A (ja) | 2008-01-24 |
| JP2008501649A5 true JP2008501649A5 (enExample) | 2010-09-24 |
| JP4594386B2 JP4594386B2 (ja) | 2010-12-08 |
Family
ID=34982058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513783A Expired - Fee Related JP4594386B2 (ja) | 2004-06-02 | 2005-05-24 | ヒスタミン３受容体のリガンドとして有用なナフタレン誘導体 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7259158B2 (enExample) |
| EP (1) | EP1755593B1 (enExample) |
| JP (1) | JP4594386B2 (enExample) |
| KR (1) | KR100854212B1 (enExample) |
| CN (1) | CN1960727B (enExample) |
| AR (1) | AR049433A1 (enExample) |
| AT (1) | ATE383857T1 (enExample) |
| AU (1) | AU2005249196B2 (enExample) |
| BR (1) | BRPI0511778A (enExample) |
| CA (1) | CA2566526C (enExample) |
| DE (1) | DE602005004404T2 (enExample) |
| DK (1) | DK1755593T3 (enExample) |
| ES (1) | ES2299074T3 (enExample) |
| IL (1) | IL179370A (enExample) |
| MX (1) | MXPA06014017A (enExample) |
| MY (1) | MY139704A (enExample) |
| NO (1) | NO20065733L (enExample) |
| NZ (1) | NZ550764A (enExample) |
| PL (1) | PL1755593T3 (enExample) |
| PT (1) | PT1755593E (enExample) |
| RU (1) | RU2387638C2 (enExample) |
| TW (1) | TWI299992B (enExample) |
| WO (1) | WO2005117865A1 (enExample) |
| ZA (1) | ZA200609678B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007097149A1 (ja) | 2006-02-20 | 2007-08-30 | Konica Minolta Holdings, Inc. | 有機エレクトロルミネッセンス素子、白色発光素子、表示装置、及び照明装置 |
| EP2079694B1 (en) | 2006-12-28 | 2017-03-01 | Rigel Pharmaceuticals, Inc. | N-substituted-heterocycloalkyloxybenzamide compounds and methods of use |
| JP5698887B2 (ja) | 2007-05-03 | 2015-04-08 | セファロン、インク． | （ｒ）−２−メチルピロリジンおよび（ｓ）−２−メチルピロリジンならびにその酒石酸塩を調製するための方法 |
| KR101573091B1 (ko) | 2007-11-16 | 2015-11-30 | 리겔 파마슈티칼스, 인크. | 대사성 장애를 위한 카르복스아미드, 술폰아미드 및 아민 화합물 |
| CA2707047C (en) | 2007-12-12 | 2017-11-28 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| CA2722139C (en) | 2008-04-23 | 2017-04-11 | Rigel Pharmaceuticals, Inc. | Carboxamide compounds for the treatment of metabolic disorders |
| EP2569280B1 (en) | 2010-05-11 | 2015-02-25 | Sanofi | Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof |
| WO2011143145A1 (en) | 2010-05-11 | 2011-11-17 | Sanofi | Substituted n-alkyl and n-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| EP2569294B1 (en) | 2010-05-11 | 2015-03-11 | Sanofi | Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| TW201206444A (en) | 2010-05-11 | 2012-02-16 | Sanofi Aventis | Substituted N-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| TW201202251A (en) | 2010-05-11 | 2012-01-16 | Sanofi Aventis | Substituted N-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| JP2013529198A (ja) | 2010-05-11 | 2013-07-18 | サノフイ | 置換されたｎ−ヘテロシクロアルキルビピロリジニルフェニルアミド誘導体、その製造及び治療上の使用 |
| KR101408699B1 (ko) | 2012-02-29 | 2014-06-19 | 중앙대학교 산학협력단 | 지르코늄 선택적 형광 프루브 |
| TWI631097B (zh) * | 2012-07-27 | 2018-08-01 | 百健Ｍａ公司 | 作爲ｓ１ｐ調節劑及／或ａｔｘ調節劑之化合物 |
| ES2684995T3 (es) | 2012-07-27 | 2018-10-05 | Biogen Ma Inc. | Derivados del ácido 2-(1-(1-(6-((ciclohexil)oxi)-5-(trifluorometil)naftalen-2-il)etil)piperidin-3-il)acético como moduladores de la autotaxina (atx) para el tratamiento de inflamaciones y trastornos autoinmunes |
| PL2888243T3 (pl) * | 2012-08-23 | 2017-01-31 | Suven Life Sciences Limited | Związki akryloamidowe jako ligandy receptora histaminowego H3 |
| CN117229207B (zh) * | 2023-09-01 | 2024-09-03 | 浙江工业大学 | 一种苯基萘类化合物及其制备与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19621483A1 (de) * | 1996-05-29 | 1997-12-04 | Hoechst Ag | Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CN1159292C (zh) * | 1996-05-31 | 2004-07-28 | 法玛西雅厄普约翰美国公司 | 用作选择性多巴胺d3配体的芳基取代的环胺类化合物 |
| AU2002254114A1 (en) * | 2001-03-23 | 2002-10-08 | Eli Lilly And Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| GB0224557D0 (en) * | 2002-10-22 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| EP1569637A1 (en) * | 2002-11-12 | 2005-09-07 | Abbott Laboratories | Bicyclic-substituted amines as histamine-3 receptor ligands |
| ATE517882T1 (de) * | 2004-10-19 | 2011-08-15 | Hoffmann La Roche | Chinolinderivate |
-
2005
- 2005-05-24 CN CN2005800178164A patent/CN1960727B/zh not_active Expired - Fee Related
- 2005-05-24 BR BRPI0511778-0A patent/BRPI0511778A/pt not_active IP Right Cessation
- 2005-05-24 DE DE602005004404T patent/DE602005004404T2/de not_active Expired - Lifetime
- 2005-05-24 WO PCT/EP2005/005594 patent/WO2005117865A1/en not_active Ceased
- 2005-05-24 AT AT05775021T patent/ATE383857T1/de active
- 2005-05-24 DK DK05775021T patent/DK1755593T3/da active
- 2005-05-24 NZ NZ550764A patent/NZ550764A/en unknown
- 2005-05-24 RU RU2006146621/04A patent/RU2387638C2/ru not_active IP Right Cessation
- 2005-05-24 KR KR1020067025300A patent/KR100854212B1/ko not_active Expired - Fee Related
- 2005-05-24 AU AU2005249196A patent/AU2005249196B2/en not_active Ceased
- 2005-05-24 MX MXPA06014017A patent/MXPA06014017A/es active IP Right Grant
- 2005-05-24 ES ES05775021T patent/ES2299074T3/es not_active Expired - Lifetime
- 2005-05-24 CA CA2566526A patent/CA2566526C/en not_active Expired - Fee Related
- 2005-05-24 EP EP05775021A patent/EP1755593B1/en not_active Expired - Lifetime
- 2005-05-24 JP JP2007513783A patent/JP4594386B2/ja not_active Expired - Fee Related
- 2005-05-24 PT PT05775021T patent/PT1755593E/pt unknown
- 2005-05-24 PL PL05775021T patent/PL1755593T3/pl unknown
- 2005-05-31 TW TW094117927A patent/TWI299992B/zh active
- 2005-05-31 MY MYPI20052479A patent/MY139704A/en unknown
- 2005-05-31 AR ARP050102236A patent/AR049433A1/es not_active Application Discontinuation
- 2005-06-01 US US11/142,738 patent/US7259158B2/en not_active Expired - Fee Related
-
2006
- 2006-11-16 IL IL179370A patent/IL179370A/en not_active IP Right Cessation
- 2006-11-21 ZA ZA200609678A patent/ZA200609678B/xx unknown
- 2006-12-12 NO NO20065733A patent/NO20065733L/no not_active Application Discontinuation
-
2007
- 2007-06-22 US US11/821,263 patent/US7608617B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501649A5 (enExample) | ||
| JP2007500753A5 (enExample) | ||
| RU2011129383A (ru) | Производное амина, обладающее антагостической активностью в отношении рецептора npy y5 | |
| WO2008006043A3 (en) | 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents | |
| JP2005514410A5 (enExample) | ||
| JP2005523310A5 (enExample) | ||
| JP2009541415A5 (enExample) | ||
| EA201000395A1 (ru) | Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида | |
| EP2085388A4 (en) | NEW 1,2-DIHYDROCHINOLINE DERIVATIVE WITH SUBSTITUTED PHENYLAMINOENE ALKYL GROUP AND PHENYL GROUP INTRODUCED BY AN ESTER AS SUBSTITUENTS | |
| HUS1500006I1 (hu) | Benzotiazol-származék vegyületek, kompozíciók és alkalmazások | |
| JP2010520851A5 (enExample) | ||
| JP2008519084A5 (enExample) | ||
| HRP20080529T3 (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
| JP2004535380A5 (enExample) | ||
| NO20061317L (no) | Imidazopyridinderivater som induserbare NO-syntaseinhibatorer | |
| JP2009075520A5 (enExample) | ||
| SG151306A1 (en) | Novel benzothiazoles and the use thereof as medicaments | |
| HRP20080447T3 (en) | 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof | |
| JP2008501844A5 (enExample) | ||
| JP2003504349A5 (enExample) | ||
| WO2008072079A3 (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide | |
| DK1613594T3 (da) | 4-(2-Phenylsulfanyl-phenyl)-1,2,3,6-tetrahydropyridin derivater som serotonin-genoptagelseshæmmere | |
| JP2011057638A5 (enExample) | ||
| WO2008099076A3 (fr) | Derives de n-(4-cyano-l h-p yrazol-3 -yl)methylamine substitues, leur preparation et leur application en therapeutique | |
| NO20061316L (no) | Imidazopyndinderivater som induserbare NO-syntaseinhibitorer |